Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesMalignant neoplasms of male genital organsICD-10-CM c62-malignant-neoplasm-of-testis
    Ask Trek AI about this page

    ICD-10-CM Code For Malignant Neoplasm Of Testis: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group C62 includes malignant neoplasms of the testis, covering primary testicular cancers such as seminomas, embryonal carcinomas, yolk sac tumors, choriocarcinomas, teratomas, and mixed germ cell tumors. These ICD-10-CM diagnosis codes are used to document primary testicular malignancy, capturing tumor laterality, histologic type when applicable, and any clinical complexity related to staging or treatment. Accurate coding within the ICD-10-CM C62 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Malignant Neoplasm Of Testis: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM C62: Malignant Neoplasm Of Testis Overview

    This group covers malignant tumors originating in the testicular tissue, including seminomas and nonseminomatous germ cell tumors that affect the male reproductive system. Accurate coding identifies tumor laterality, histologic subtype when required, and stage-related documentation, which supports appropriate claim processing and reimbursement. Precise documentation and code selection are essential for reflecting clinical complexity and ensuring correct payment.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when a confirmed primary malignant neoplasm of the testis is documented by clinical, radiologic, or pathologic evaluation. Select the code that specifies laterality and histologic subtype when documented to accurately reflect the diagnosis for clinical records and billing.

    ICD-10-CM Codes

    9 rows

    ICD-10-CM CodeDescription
    C62.00Malignant neoplasm of unspecified undescended testis
    C62.01Malignant neoplasm of undescended right testis
    C62.02Malignant neoplasm of undescended left testis
    C62.10Malignant neoplasm of unspecified descended testis
    C62.11Malignant neoplasm of descended right testis
    C62.12Malignant neoplasm of descended left testis
    C62.90Malignant neoplasm of unspecified testis, unspecified whether descended or undescended
    C62.91Malignant neoplasm of right testis, unspecified whether descended or undescended
    C62.92Malignant neoplasm of left testis, unspecified whether descended or undescended

    DRG Codes

    5 rows

    DRG CodeDescription
    715Other Male Reproductive System O.R. Procedures for Malignancy with CC/MCC
    716Other Male Reproductive System O.R. Procedures for Malignancy without CC/MCC
    722Malignancy, Male Reproductive System with MCC
    723Malignancy, Male Reproductive System with CC
    724Malignancy, Male Reproductive System without CC/MCC

    Typical Clinical Scenarios

    • A 28-year-old man presents to the emergency department with sudden, severe unilateral testicular pain and swelling after minor trauma. Scrotal ultrasound shows a heterogeneous intratesticular mass distinct from hemorrhage, and tumor markers are elevated; urgent urology evaluation leads to radical inguinal orchiectomy with pathology confirming a primary malignant testicular tumor of the right testis. A code from this group is assigned to report the primary malignant neoplasm of the right testis. Typical codes: C62.11, C62.12
    • A 45-year-old man in outpatient oncology follow-up has a known history of a treated malignant tumor originally involving the left testis; he now reports a new palpable mass in the contralateral testis found on surveillance exam and imaging consistent with a new primary intratesticular malignancy. The visit documents clinical assessment and staging workup for a left testicular cancer, so a code from this group is used to report the malignant neoplasm of the left testis. Typical codes: C62.01, C62.02
    • A 62-year-old male with metastatic disease presents for palliative care and has a history of testicular cancer treated previously; current records show an unspecified testicular malignancy being managed for symptom control without recent laterality determination in the record. Because the encounter documents ongoing care for a malignant testicular neoplasm without specific laterality, an unspecified testis code from this group is assigned. Typical codes: C62.90, C62.92

    Related Codes

    C60-MALIGNANT-NEOPLASM-OF-PENIS

    ICD-10-CM Code For Malignant Neoplasm Of Penis: Group Overview

    C61-MALIGNANT-NEOPLASM-OF-PROSTATE

    ICD-10-CM Code For Malignant Neoplasm Of Prostate: Group Overview

    C63-MALIGNANT-NEOPLASM-MALE-GENITAL

    ICD-10-CM Code For Malignant Neoplasm Of Other And Unspecified Male Genital Organs: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.